Schonfeld Strategic Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-33,601
Closed -$599K 2052
2025
Q3
$599K Sell
33,601
-100,876
-75% -$1.46M ﹤0.01% 1615
2025
Q2
$1.46M Buy
134,477
+19,890
+17% +$261K 0.01% 1141
2025
Q1
$2.12M Buy
114,587
+51,287
+81% +$925K 0.01% 938
2024
Q4
$1.04M Sell
63,300
-220,449
-78% -$3.12M 0.01% 1090
2024
Q3
$3.98M Buy
+283,749
New +$3.14M 0.03% 622
2023
Q3
Sell
-78,800
Closed -$719K 1770
2023
Q2
$719K Buy
78,800
+14,363
+22% +$134K 0.01% 1095
2023
Q1
$609K Buy
64,437
+7,750
+14% +$70.9K 0.01% 1117
2022
Q4
$566K Buy
56,687
+45,987
+430% +$511K ﹤0.01% 1461
2022
Q3
$127K Buy
+10,700
New +$107K ﹤0.01% 2489
2022
Q1
Sell
-19,000
Closed -$178K 2582
2021
Q4
$178K Buy
19,000
+242
+1% +$2.9K ﹤0.01% 1772
2021
Q3
$297K Sell
18,758
-642
-3% -$11.5K ﹤0.01% 1538
2021
Q2
$419K Sell
19,400
-4,000
-17% -$80.8K ﹤0.01% 1277
2021
Q1
$474K Sell
23,400
-5,100
-18% -$101K 0.01% 1165
2020
Q4
$510K Buy
+28,500
New +$419K 0.01% 1031
2020
Q3
Sell
-24,919
Closed -$230K 1361
2020
Q2
$230K Buy
+24,919
New +$223K 0.01% 1067
2019
Q3
Sell
-46,400
Closed -$919K 1015
2019
Q2
$919K Sell
46,400
-163,000
-78% -$3.49M 0.03% 471
2019
Q1
$4.41M Buy
+209,400
New +$3.83M 0.15% 177
2018
Q3
Sell
-40,000
Closed -$2.01M 800
2018
Q2
$2.01M Sell
40,000
-80,000
-67% -$3.52M 0.11% 268
2018
Q1
$4.38M Hold
120,000
0.33% 84
2017
Q4
$3.4M Hold
120,000
0.28% 104
2017
Q3
$2.32M Hold
120,000
0.21% 139
2017
Q2
$2.01M Hold
120,000
0.21% 146
2017
Q1
$1.25M Hold
120,000
0.13% 226
2016
Q4
$1.08M Buy
+120,000
New +$1.03M 0.14% 219

Other funds holding AXGN

Schonfeld Strategic Advisors's AXGN Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Axogen (AXGN) in Q4 2025, closing a stake of 33,601 shares — an estimated $599K sold.

Schonfeld Strategic Advisors first reported a position in AXGN in Q4 2016 and held it in 24 quarters. The position peaked at $4.41M in Q1 2019. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining Axogen position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 33,601 Axogen shares in Q4 2025, an estimated $599K.
  • Schonfeld Strategic Advisors first reported a position in Axogen in Q4 2016 and held it in 24 quarters.
  • Schonfeld Strategic Advisors's Axogen position peaked at $4.41M in Q1 2019.
  • 208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.